Cigna Group $CI Shares Acquired by Clark Capital Management Group Inc.

Clark Capital Management Group Inc. increased its position in Cigna Group (NYSE:CI) by 45.5% in the 3rd quarter, Holdings Channel.com reports. The firm owned 240,372 shares of the health services provider’s stock after buying an additional 75,121 shares during the quarter. Clark Capital Management Group Inc.’s holdings in Cigna Group were worth $69,287,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CI. Norges Bank acquired a new position in Cigna Group in the 2nd quarter worth $1,110,426,000. Capital Research Global Investors grew its stake in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Ameriprise Financial Inc. grew its stake in shares of Cigna Group by 54.5% during the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after acquiring an additional 492,045 shares during the last quarter. Finally, Balyasny Asset Management L.P. lifted its stake in shares of Cigna Group by 1,057.2% in the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after acquiring an additional 369,775 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Trading Up 0.5%

Shares of NYSE CI opened at $267.15 on Friday. The stock’s 50 day moving average price is $279.60 and its two-hundred day moving average price is $282.82. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The stock has a market capitalization of $70.40 billion, a P/E ratio of 12.04, a PEG ratio of 0.93 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter last year, the firm earned $6.64 EPS. The business’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
• Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
• Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
• Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
• Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
• Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CI. Truist Financial increased their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Royal Bank Of Canada cut their target price on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. Mizuho set a $325.00 target price on Cigna Group in a research note on Friday, January 9th. UBS Group reissued a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Finally, Barclays dropped their price target on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.